Beckman Coulter, Inc.
250 S Kraemer Blvd
Brea
CA
92821
United States
Tel: (714) 993-5321
Website: http://www.beckmancoulter.com/
326 articles about Beckman Coulter, Inc.
-
Beckman Coulter, Lenco Diagnostic Laboratories deliver more than 20,000 highly accurate COVID-19 antibody tests each week to New York City; Congressman Max Rose and Brooklyn Borough President Eric Adams applaud boost in testing resources
7/6/2020
40,000 of Beckman Coulter's new Access SARS-CoV-2 IgG Antibody tests already received by New York City through Lenco Labs
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for June 29, 2020.
-
Beckman Coulter's SARS-CoV-2 IgG Antibody Test Receives FDA Emergency Use Authorization
6/29/2020
Beckman Coulter today announced that its Access SARS-CoV-2 IgG assay has received Emergency Use Authorization (EUA) from the U.S. Food & Drug Administration (FDA). Beckman Coulter has already shipped tests to more than 400 hospitals, clinics and diagnostics laboratories in the U.S., and has begun distribution of the new antibody test globally to countries that accept the FDA EUA and CE Mark.
-
Beckman Coulter announces May launch of its SARS-CoV-2 serology test and ramps production to deliver over 30 million tests per month
4/22/2020
Building on its strong commitment to the fight against coronavirus, Beckman Coulter announced a mid-May launch timeline for its new Access SARS-CoV-2 IgG serology test and plans to achieve market-leading production volumes that will ramp to more than 30 million tests per month.
-
Beckman Coulter announces development of tests to detect coronavirus antibodies
3/31/2020
New IgM and IgG antibody assays will help indicate whether a person potentially developed immunity against the coronavirus (SARS-CoV-2)
-
Beckman Coulter announces installation of DxH 900 and Early Sepsis Indicator at award-winning NHS pathology partnership
1/7/2020
Beckman Coulter, a global leader in clinical diagnostics, announced that South West London Pathology has implemented DxH 900 haematology analysers and the Early Sepsis Indicator across the SWLP network.
-
Beckman Coulter receives BARDA funding to develop algorithm to aid in the early detection of sepsis*
10/29/2019
Beckman Coulter, Inc., a Danaher company, today announced that it has initially been awarded a contract of $1.25 million, with potential to be awarded an additional $6.5 million if all contract options are exercised,
-
Beckman Coulter's DxA 5000 total laboratory automation solution receives U.S. FDA 510(k) clearance
10/9/2019
Research shows errors that occur in the pre-analytical phase of testing may contribute up to 75% of erroneous test results, with 26% possibly having an adverse effect on patient care.
-
Beckman Coulter's DxH 520 Hematology Analyzer receives Scientists' Choice Award and Named Best New Clinical Product
8/7/2019
Beckman Coulter, a global leader in clinical diagnostics, announced today that its small, but mighty DxH 520 hematology analyzer received the Scientists' Choice Award® for Best New Clinical Laboratory Product of 2018.
-
Beckman Coulter MicroScan Wins IMV ServiceTrak™ Best System Performance for the Second Year in a Row
8/6/2019
The Best System Performance award was presented to Beckman Coulter today at the 71st AACC Annual Scientific Meeting & Clinical Lab Expo in Anaheim, Calif.
-
Laboratories of all Sizes Can Now Harness the Power of Automation with Beckman Coulter
8/1/2019
Visit booth 3201 at AACC 2019 to experience how automation helps solve the unique challenges of small-, mid- and high-volume laboratories
-
Beckman Coulter's Early Sepsis Indicator Receives 510(k) Clearance from the U.S. Food and Drug Administration
4/18/2019
New hematologic biomarker has the potential to revolutionize clinicians' approach to sepsis triage and diagnosis
-
Beckman Coulter's Compact, Low-volume Hematology Analyzer Receives FDA 510(k) Clearance
3/21/2019
With just 17 microliters of blood, the DxH 520 enables low-volume laboratories to deliver 5-part differential test results in 60 seconds or less
-
Beckman Coulter's HbA1c Advanced Assay Provides Physicians with Greater Accuracy when Diagnosing Patients with Diabetes
3/7/2019
New assay achieves CE Mark Certification and U.S. FDA 501(k) Clearance
-
Beckman Coulter's New DxONE Inventory Manager Helps Laboratory Professionals Save Time and Money
11/27/2018
Cloud-based solution streamlines labor-intensive inventory management tasks to improve resource management
-
Beckman Coulter Life Sciences Announces Research-Focused Beckman.com
10/19/2018
Ongoing Customer-Driven Site Enhancements Designed to Improve User Experience
-
Beckman Coulter Diagnostics Joins Forces with Johns Hopkins Medicine in Healthcare Innovation Initiative
10/16/2018
Beckman Coulter Diagnostics, a global leader in the clinical diagnostics industry, is embarking on an innovation collaboration with Johns Hopkins Medicine to explore co-innovation initiatives with the goal of developing and commercializing novel solutions that address challenges in healthcare.
-
BioBright and Beckman Coulter Announce a Strategic Partnership to Bring Enhanced Technical Support Capabilities to Instruments
9/18/2018
BioBright and Beckman Coulter announce a strategic partnership to bring enhanced technical support capabilities to instruments.
-
Beckman Coulter Announces Release of Latest Innovations to Middleware Software
9/10/2018
REMISOL Advance* v1.10 software helps to ensure continuous operations and efficient delivery of critical results by giving mid- to high-volume laboratories real-time, actionable analytics at-a-glance
-
Beckman Coulter Sponsors 2nd World Sepsis Conference
9/4/2018
Beckman Coulter, a global leader in the clinical diagnostics industry, announced today that it is a gold sponsor of the 2nd World Sepsis Congress, a free-of-charge online conference, hosted by the Global Sepsis Alliance, that will be held Sept. 5 and 6, 2018.